UnitedHealth Prognosis Mixed: Analysts Trim Targets But Keep Faith After Q2 Miss

Shares of UnitedHealth Group Inc (NYSE:UNH) remained volatile in early trading on Wednesday, after a downbeat second-quarter report.

Here are some key analyst takeaways.

Piper Sandler analyst Jessica Tassan maintained an Overweight rating, while reducing the price target from $353 to $317.

KeyBanc Capital Markets analyst Matthew Gillmor maintained an Overweight rating, while cutting the price target from $400 to $350.

Oppenheimer analyst Michael Wiederhorn reaffirmed an Outperform rating, while lowering the price target from $400 to $325.

Check out other analyst stock ratings.

Piper Sandler: UnitedHealth provided "unprecedented transparency into business mix, earnings drivers and pricing assumptions/ cost trends across UHC and Optum," Tassan said in a note. Management reinstated its full-year guidance.

Adjusted earnings of $16 per share are shy of the $18-$19 per share consensus.

The company seems to have diagnosed ...